1-833-ZEPOSIA

ZEPOSIA is a once-daily pill for adults with relapsing multiple sclerosis (MS).

Take as directed by your doctor if certain liver problems exist.

MenuClose

ZEPOSIA is a once-daily pill for adults with relapsing multiple sclerosis (MS).

Take as directed by your doctor if certain liver problems exist.

Treat both the visible and invisible signs of MS

Here’s a quick look at some key things you should know about ZEPOSIA.

ZEPOSIA® pill icon

One pill, once a day

ZEPOSIA is not an injection or an infusion—you can take it when and where you want, with or without food.

ZEPOSIA Clinical Study Results Icon

ZEPOSIA treats the visible and invisible signs of MS

ZEPOSIA helps protect the brain from the damaging effects of MS by reducing relapses and new or enlarging lesions.*

See study results 
  • In a 2-year study, people taking ZEPOSIA had 38% fewer relapses and 42% fewer new or enlarging lesions (T2) than those taking Avonex® (interferon beta-1a). There was no significant difference in disability progression between people taking ZEPOSIA and those taking Avonex.
ZEPOSIA® Study Experience Icon

Studied for nearly 10 years

ZEPOSIA has been studied for nearly 10 years across 6 clinical trials in 2 conditions—multiple sclerosis and ulcerative colitis.

Explore safety 
  • Earliest trials in patients with multiple sclerosis and patients with ulcerative colitis started in 2012.
ZEPOSIA® Patients Prescribed Icon

Received by ~52,000 patients since approval

Approximately 52,000 patients have received ZEPOSIA across both conditions.

Hear from one of those patients below.

  • As of May 2024.
Mia, real ZEPOSIA® patient Mia, real ZEPOSIA® patient
Quotation mark icon

A year after starting ZEPOSIA, I hadn’t had any relapses or new active lesions.§

—Mia

A real ZEPOSIA patient compensated for her time.

§ZEPOSIA was compared to Avonex in 2 separate clinical trials.

(Individual results may vary.)

Watch Mia’s story
ZEPOSIA® Co-pay Program icon

Save on the cost of ZEPOSIA

Eligible, commercially insured patients may pay as little as $0 a month for ZEPOSIA. Click here for eligibility requirements and terms & conditions.

Learn about support

2084-US-2301364 01/24